Postherpetic myelitis
ICD-10 B02.24 is a billable code used to indicate a diagnosis of postherpetic myelitis.
Postherpetic myelitis is a rare but serious complication that can occur following a herpes zoster (shingles) infection. It is characterized by inflammation of the spinal cord, which can lead to neurological deficits. The condition typically arises after the resolution of the herpes zoster rash, often in older adults or immunocompromised individuals. Symptoms may include severe pain, weakness, sensory loss, and in some cases, paralysis. The pathophysiology involves the reactivation of the varicella-zoster virus (VZV), which can cause inflammation in the central nervous system. Diagnosis is primarily clinical, supported by imaging studies such as MRI to assess spinal cord involvement and rule out other causes. Treatment focuses on managing symptoms and may include antiviral medications, corticosteroids, and pain management strategies. Early recognition and intervention are crucial to minimize long-term complications.
Detailed neurological examination findings, imaging results, and treatment plans.
Patients presenting with new neurological deficits following shingles.
Ensure comprehensive documentation of neurological assessments and any co-existing conditions.
History of herpes zoster infection, treatment history, and immunization status.
Patients with recurrent herpes zoster or complications from prior infections.
Document vaccination history and any immunocompromised status.
Used for follow-up visits for patients with postherpetic myelitis.
Document history, examination findings, and treatment plan.
Neurology specialists should ensure detailed neurological assessments are included.
Postherpetic myelitis is primarily caused by the reactivation of the varicella-zoster virus, which leads to inflammation of the spinal cord following a shingles infection.
